April 18, 2019
Via: medicaldevice-network.comA blood test developed by Natera could detect early stage breast cancer relapse nearly two years quicker than current imaging technologies. Called Signatera, the test conducts molecular residual disease (MRD) analysis to identify trace amounts of mutated DNA produced by […]
May 18, 2023
May 11, 2023
Copyright © 2023. All rights reserved
